Search Results

The Conceptus FTCM System is intended for use in selective catheterization/cannulation of the fallopian tubes in order to evaluate proximal tubal occlusion or patency under direct visualization.

The FTCM System combines well-established procedures of HSG, co-axial catheterization and microendoscopy. The FTCM System is composed of the following components: Soft Seal Cervical Catheter, Soft Torque Uterine Catheter and Accessory Valve, and/or Articulating Tip Hysteroscope, Variable Softness Catheter, guidewires: the Robust Guidewire, the Traveler Guidewire, the Supple Guidewire and the Pirouette Guidewire, and a Microendoscope with Eyepiece.

The provided text describes a medical device, the FTCM System, and states its intended use. However, it does not contain specific acceptance criteria or details of a study proving the device meets acceptance criteria.

The document focuses on:

• Device Description: Detailed breakdown of each component of the FTCM System (Catheters, Hysteroscope, Guidewires, Microendoscope, Eyepiece).
• Indications for Use: What the device is intended for (selective catheterization/cannulation of fallopian tubes to evaluate occlusion or patency under direct visualization).
• Substantial Equivalence: A statement that the FTCM System is substantially equivalent to a previous system (Conceptus FTC System) based on "comparative performance testing" related to "force required to navigate the fallopian tube model" and further "performance testing and clinical data."

Therefore, I cannot populate the table or answer the specific questions about acceptance criteria and a study proving the device meets them based on the provided text. The text mentions "comparative performance testing" and "clinical data" but gives no specifics about the acceptance criteria, study design, sample sizes, ground truth establishment, or expert involvement for those tests.

Ask a specific question about this device